A leading developer of microencapsulation solutions Q Chip has appointed Ken Powell as executive chairman.
With a career spanning more than three decades as a senior researcher and manager in the pharmaceutical sector Powell is widely acknowledged by the industry as one of its pioneers. His previous positions include ceo Arrow Therapeutics, head of Antiviral Research and head of Biology at the Wellcome Foundation and Professor of Virology and Cell Biology at the Wolfson Institute for Biomedical Research at University College, London. Powell said: "I have accepted the role of executive chairman of Q Chip for the simple reason I am excited by its prospects. It has undertaken some very exciting research, which provides the foundations for a strong pipeline of applications and products. The product opportunities presented by Q Chip's technology will offer cost effective solutions to some of the most pressing issues in the biotech industry. I am particularly delighted to have the opportunity to assist Q Chip in the development of its MicroPlantTM drug delivery technology and expanding the commercial reach of its unique ReaX range of easy to use, beaded molecular reagents."